kabutan

D.Western Therapeutics Institute, The Current Fiscal Year's Net Income to Widen

Fri Feb 13, 2026 3:30 pm JST Earnings

4576 D.Western Therapeutics Institute, Inc. 【J-GAAP】

Earnings Report

D.Western Therapeutics Institute, Inc. <4576> [TSE Growth] announced its financial results after the market closed on February 13th (15:30). The consolidated net loss for the fiscal year ended December 2025 was loss of 0.63 billion yen, a reduction in the deficit compared to loss of 1.29 billion yen in the previous term. For the fiscal year ending December 2026, the consolidated net loss is expected to be loss of 0.80 billion yen. This will mark the seventh consecutive term of losses.

In the most recent three-month period, from October to December (4Q), the consolidated net loss improved to a deficit of 0.14 billion yen (compared to a loss of 0.56 billion yen in the same period last year). The operating profit/loss margin improved from -456.9% in the same period last year to -156.7%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 428 -798 -796 -812 -25.6 0 Feb 9, 2024 J-GAAP
Dec, 2024 471 -1,209 -1,228 -1,290 -36.7 0 Feb 10, 2025 J-GAAP
Dec, 2025 387 -619 -630 -632 -13.2 0 Feb 13, 2026 J-GAAP
YoY -17.8% +48.8% +48.7% +51.0% +64.1%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2025 Guidance 400 -670 -680 -680 -12.5 0 Feb 10, 2025 J-GAAP
Dec, 2025 Results 387 -619 -630 -632 -13.2 0 Feb 13, 2026 J-GAAP
Revision Rate -3.3% +7.6% +7.4% +7.1% -5.3%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 173 -309 -316 -316 -7.1 0 Aug 14, 2025 J-GAAP
Jan - Jun, 2026 Guidance ー ー ー ー － 0 Feb 13, 2026 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 471 -1,209 -1,228 -1,290 -36.7 0 Feb 10, 2025 J-GAAP
Dec, 2025 387 -619 -630 -632 -13.2 0 Feb 13, 2026 J-GAAP
Dec, 2026 Guidance 300 -780 -800 -800 -14.8 0 Feb 13, 2026 J-GAAP
YoY -22.5% -26.0% -27.0% -26.6% -11.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 123 -562 -563 -563 -16.0 -456.9 Feb 10, 2025 J-GAAP
Jan - Mar, 2025 96 -142 -149 -150 -3.4 -147.9 May 15, 2025 J-GAAP
Apr - Jun, 2025 77 -167 -167 -166 -3.7 -216.9 Aug 14, 2025 J-GAAP
Jul - Sep, 2025 124 -169 -175 -176 -3.9 -136.3 Nov 13, 2025 J-GAAP
Oct - Dec, 2025 90 -141 -139 -140 -2.9 -156.7 Feb 13, 2026 J-GAAP
YoY -26.8% +74.9% +75.3% +75.1% +81.8%

Related Articles